1
Postma, Maarten J., Novak, Annoesjka, Scheijbeler, Huib W. K. F. H., Gyldmark, Marlene, van Genugten, Marianne L. L., Wilschut, Jan C.
Veröffentlicht in: Postma , M J , Novak , A , Scheijbeler , H W K F H , Gyldmark , M , van Genugten , M L L & Wilschut , J C 2007 , ' Cost effectiveness of oseltamivir treatment for patients with influenza-like illness who are at increased risk for serious complications of influenza - Illustration for the Netherlands ' , Pharmacoeconomics , vol. 25 , no. 6 , pp. 497-509 .;
2007
Veröffentlicht in: Postma , M J , Novak , A , Scheijbeler , H W K F H , Gyldmark , M , van Genugten , M L L & Wilschut , J C 2007 , ' Cost effectiveness of oseltamivir treatment for patients with influenza-like illness who are at increased risk for serious complications of influenza - Illustration for the Netherlands ' , Pharmacoeconomics , vol. 25 , no. 6 , pp. 497-509 .;
2007
2
Westra, Tjalke A., Stirbu-Wagner, Irina, Dorsman, Sara, Tutuhatunewa, Eric D., de Vrij, Edwin L., Nijman, Hans W., Daemen, Toos, Wilschut, Jan C., Postma, Maarten J.
Veröffentlicht in: Westra , T A , Stirbu-Wagner , I , Dorsman , S , Tutuhatunewa , E D , de Vrij , E L , Nijman , H W , Daemen , T , Wilschut , J C & Postma , M J 2013 , ' Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands ' , BMC Infectious Diseases , vol. 13 , no. 1 , 75 . https://doi.org/10.1186/1471-2334-13-75;
2013
Veröffentlicht in: Westra , T A , Stirbu-Wagner , I , Dorsman , S , Tutuhatunewa , E D , de Vrij , E L , Nijman , H W , Daemen , T , Wilschut , J C & Postma , M J 2013 , ' Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands ' , BMC Infectious Diseases , vol. 13 , no. 1 , 75 . https://doi.org/10.1186/1471-2334-13-75;
2013